Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3312

TDMS Study 05121-05 Pathology Tables

NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96
Route: GAVAGE                                                                                                     Time: 21:10:36




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  6533-68-2

       Lock Date:  05/14/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          60           60           60           60                                     

  Scheduled Sacrifice                                 10                        10           10                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                13           10            6            7                                     
    Natural Death                                      3           15           16           16                                     
    Dosing Accident                                                 2            2            5                                     
    Accidently Killed                                              16                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           17           26           22                                     

  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (60)         (59)         (57)         (57)                                   
      Parasite Metazoan                                2 (3%)       4 (7%)       2 (4%)       5 (9%)                                
   Intestine Large, Rectum                            (60)         (59)         (57)         (57)                                   
      Parasite Metazoan                                7 (12%)      2 (3%)       4 (7%)                                             
   Intestine Small, Duodenum                          (60)         (60)         (60)         (59)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Intestine Small, Jejunum                           (59)         (56)         (57)         (56)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
   Liver                                              (60)         (60)         (60)         (60)                                   
      Basophilic Focus                                22 (37%)     11 (18%)     21 (35%)     23 (38%)                               
      Clear Cell Focus                                 1 (2%)       1 (2%)                                                          
      Eosinophilic Focus                               3 (5%)       4 (7%)       4 (7%)       5 (8%)                                
      Fatty Change                                     2 (3%)       1 (2%)                    1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                      14 (23%)      9 (15%)      6 (10%)     11 (18%)                               
      Hyperplasia, Adenomatous                         1 (2%)                                                                       
      Inflammation, Acute, Focal                       1 (2%)                                                                       
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mixed Cell Focus                                 1 (2%)                                                                       
      Necrosis                                                                   1 (2%)                                             
      Bile Duct, Inflammation, Chronic                              1 (2%)                                                          
      Serosa, Fibrosis                                                                        1 (2%)                                
   Mesentery                                          (1)          (3)          (3)          (2)                                    
      Fat, Necrosis                                    1 (100%)     3 (100%)     2 (67%)      2 (100%)                              
      Lymphatic, Cyst                                                            1 (33%)                                            
   Pancreas                                           (60)         (60)         (60)         (60)                                   
      Acinus, Atrophy                                 16 (27%)      7 (12%)      8 (13%)      6 (10%)                               
      Artery, Inflammation, Chronic                                 1 (2%)                                                          
      Duct, Concretion                                                                        1 (2%)                                
   Salivary Glands                                    (60)         (60)         (60)         (60)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Subacute                           1 (2%)                                                                       
   Stomach, Forestomach                               (60)         (60)         (60)         (58)                                   
      Hyperkeratosis                                   1 (2%)                                                                       
      Ulcer                                            2 (3%)       1 (2%)       1 (2%)                                             
   Stomach, Glandular                                 (60)         (60)         (60)         (59)                                   
      Ulcer                                            3 (5%)                    1 (2%)       1 (2%)                                
      Artery, Mineralization                           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (60)         (60)         (60)         (59)                                   
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
   Heart                                              (60)         (60)         (60)         (60)                                   
      Atrium, Thrombosis                                            1 (2%)       1 (2%)       1 (2%)                                
      Myocardium, Degeneration                        30 (50%)     17 (28%)     31 (52%)     24 (40%)                               
      Myocardium, Mineralization                       1 (2%)                                                                       
      Valve, Thrombosis                                                          1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)         (60)                                   
      Degeneration                                     1 (2%)                                                                       
      Hyperplasia                                     11 (18%)      5 (8%)       6 (10%)      4 (7%)                                
   Adrenal Medulla                                    (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)       1 (2%)       1 (2%)                                             
      Bilateral, Hyperplasia                                                                  1 (2%)                                
   Pituitary Gland                                    (60)         (60)         (60)         (60)                                   
      Cyst                                            39 (65%)     28 (47%)     37 (62%)     31 (52%)                               
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Pars Distalis, Angiectasis                       1 (2%)                    1 (2%)       1 (2%)                                
      Pars Distalis, Hyperplasia                      16 (27%)     11 (18%)     16 (27%)     17 (28%)                               
   Thyroid Gland                                      (60)         (60)         (60)         (60)                                   
      C-Cell, Hyperplasia                              5 (8%)       1 (2%)       2 (3%)       2 (3%)                                
      Follicular Cell, Hyperplasia                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (59)         (60)         (58)         (60)                                   
      Ectasia                                          5 (8%)       1 (2%)                                                          
      Hyperplasia                                                   2 (3%)                    1 (2%)                                
      Inflammation, Suppurative                        2 (3%)       2 (3%)       1 (2%)                                             
   Ovary                                              (60)         (60)         (60)         (60)                                   
      Cyst                                             1 (2%)       2 (3%)       1 (2%)       3 (5%)                                
   Uterus                                             (60)         (60)         (60)         (60)                                   
      Decidual Reaction                                                          1 (2%)                                             
      Dilatation                                                    1 (2%)                                                          
      Hyperplasia, Cystic                                                                     1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
   Vagina                                             (2)                       (1)                                                 
      Infiltration Cellular, Polymorphonuclear         1 (50%)                                                                      
      Epithelium, Vacuolization Cytoplasmic                                      1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)         (60)         (60)                                   
      Inflammation, Granulomatous                                                             1 (2%)                                
      Myelofibrosis                                                                           1 (2%)                                
      Myelostromal Proliferation                                    1 (2%)                                                          
   Lymph Node                                         (2)          (2)          (2)                                                 
      Renal, Pigmentation, Hemosiderin                              1 (50%)                                                         
   Lymph Node, Mandibular                             (60)         (60)         (60)         (60)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
   Lymph Node, Mesenteric                             (60)         (59)         (60)         (60)                                   
      Inflammation, Subacute                           1 (2%)                                                                       
   Spleen                                             (60)         (60)         (60)         (60)                                   
      Fibrosis                                         2 (3%)       2 (3%)       2 (3%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)       4 (7%)       1 (2%)       2 (3%)                                
      Necrosis                                                      1 (2%)       1 (2%)                                             
      Lymphoid Follicle, Atrophy                       1 (2%)                                 2 (3%)                                
      Red Pulp, Atrophy                                                                       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (60)         (60)         (60)         (58)                                   
      Edema                                                         1 (2%)                                                          
      Hyperplasia, Cystic                              2 (3%)       1 (2%)       1 (2%)                                             
      Inflammation                                                  1 (2%)                                                          
   Skin                                               (60)         (60)         (60)         (60)                                   
      Acanthosis                                                                 1 (2%)                                             
      Hyperkeratosis                                                                          1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Ulcer                                                         2 (3%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)         (60)         (60)                                   
      Osteopetrosis                                                 2 (3%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (60)                                   
      Erythrophagocytosis                              1 (2%)                                                                       
      Foreign Body                                                  1 (2%)       1 (2%)       1 (2%)                                
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Infiltration Cellular, Mononuclear Cell          1 (2%)       1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       1 (2%)                    2 (3%)                                
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Inflammation, Subacute                           1 (2%)                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (3%)       2 (3%)       4 (7%)       1 (2%)                                
      Alveolus, Edema                                               1 (2%)                                                          
      Bronchus, Inflammation, Acute                                              1 (2%)                                             
   Nose                                               (60)         (60)         (60)         (60)                                   
      Exudate                                                       1 (2%)                                                          
      Inflammation, Suppurative                                                  2 (3%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (2)          (1)                                                              
      External Ear, Ulcer                                           1 (100%)                                                        
   Eye                                                (2)          (3)          (2)                                                 
      Inflammation, Chronic                                         1 (33%)                                                         
      Anterior Chamber, Inflammation                                             1 (50%)                                            
      Cornea, Necrosis                                 1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (60)                                   
      Cyst                                             1 (2%)                                                                       
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
      Hydronephrosis                                                                          1 (2%)                                
      Infarct                                                                    1 (2%)                                             
      Nephropathy                                     35 (58%)     22 (37%)     29 (48%)     14 (23%)                               
      Pelvis, Inflammation, Chronic                                              1 (2%)                                             
   Urinary Bladder                                    (60)         (60)         (59)         (60)                                   
      Calculus Gross Observation                       1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia             1 (2%)                                 1 (2%)                                
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          60           60           60           60                                     

  Scheduled Sacrifice                                 10           10           10           10                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                23           30           20           17                                     
    Natural Death                                      5            4            7            4                                     
    Dosing Accident                                    2            2            1            1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                20           14           22           28                                     

  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (60)         (60)         (60)         (60)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
      Ulcer                                                         1 (2%)                                                          
      Periesophageal Tissue, Inflammation, Chronic     1 (2%)                                                                       
   Intestine Large, Colon                             (60)         (60)         (60)         (60)                                   
      Parasite Metazoan                                4 (7%)                    2 (3%)       2 (3%)                                
      Ulcer                                                                                   1 (2%)                                
   Intestine Large, Rectum                            (59)         (60)         (60)         (60)                                   
      Parasite Metazoan                                9 (15%)      1 (2%)       4 (7%)       3 (5%)                                
   Intestine Large, Cecum                             (60)         (60)         (59)         (60)                                   
      Parasite Metazoan                                                                       1 (2%)                                
      Ulcer                                                         1 (2%)                    1 (2%)                                
   Intestine Small, Jejunum                           (60)         (60)         (59)         (59)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
      Ulcer                                                         1 (2%)                                                          
   Intestine Small, Ileum                             (60)         (60)         (60)         (59)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
   Liver                                              (60)         (60)         (60)         (60)                                   
      Basophilic Focus                                 4 (7%)       5 (8%)       6 (10%)      5 (8%)                                
      Clear Cell Focus                                 1 (2%)       1 (2%)                    2 (3%)                                
      Cyst                                             1 (2%)                    1 (2%)                                             
      Degeneration, Cystic                             9 (15%)      3 (5%)       4 (7%)                                             
      Eosinophilic Focus                               2 (3%)       3 (5%)       2 (3%)       4 (7%)                                
      Fatty Change                                                  2 (3%)       5 (8%)       5 (8%)                                
      Hepatodiaphragmatic Nodule                       4 (7%)       5 (8%)       7 (12%)      4 (7%)                                
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic                                         1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Mixed Cell Focus                                 2 (3%)       2 (3%)                                                          
      Necrosis                                         1 (2%)                    1 (2%)       1 (2%)                                
      Centrilobular, Degeneration                      1 (2%)       1 (2%)                    1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Portal, Degeneration                                                                    1 (2%)                                
      Sinusoid, Congestion, Focal                      1 (2%)                                                                       
   Mesentery                                          (7)          (15)         (24)         (15)                                   
      Inflammation, Suppurative                                     1 (7%)                                                          
      Artery, Thrombosis                               1 (14%)                                                                      
      Fat, Inflammation                                                                       1 (7%)                                
      Fat, Necrosis                                    6 (86%)     14 (93%)     19 (79%)     13 (87%)                               
      Lymphatic, Cyst                                  1 (14%)                                                                      
   Pancreas                                           (60)         (60)         (60)         (60)                                   
      Acinus, Atrophy                                 20 (33%)     17 (28%)     10 (17%)     14 (23%)                               
      Arteriole, Inflammation, Chronic                              1 (2%)                                                          
      Artery, Inflammation, Chronic                    1 (2%)                    1 (2%)       1 (2%)                                
   Stomach, Forestomach                               (60)         (60)         (60)         (60)                                   
      Hyperkeratosis                                                                          1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Ulcer                                            3 (5%)       6 (10%)      4 (7%)       7 (12%)                               
   Stomach, Glandular                                 (60)         (60)         (60)         (60)                                   
      Erosion                                          1 (2%)                                                                       
      Mineralization                                                1 (2%)       1 (2%)                                             
      Ulcer                                            8 (13%)      6 (10%)      2 (3%)                                             
   Tongue                                                          (1)                                                              
      Foreign Body                                                  1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (60)         (60)                                   
      Atrium, Thrombosis                               3 (5%)       2 (3%)       5 (8%)       3 (5%)                                
      Myocardium, Degeneration                        48 (80%)     51 (85%)     48 (80%)     43 (72%)                               
      Valve, Inflammation, Chronic                     1 (2%)                                                                       
      Valve, Thrombosis                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      8 (13%)     10 (17%)     12 (20%)      7 (12%)                               
   Adrenal Medulla                                    (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)       5 (8%)       4 (7%)       2 (3%)                                
      Necrosis                                                      1 (2%)                                                          
   Islets, Pancreatic                                 (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)                                                                       
   Parathyroid Gland                                  (55)         (55)         (55)         (59)                                   
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (59)         (58)         (60)         (60)                                   
      Angiectasis                                                                1 (2%)                                             
      Cyst                                             5 (8%)       8 (14%)      5 (8%)       7 (12%)                               

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hyperplasia                      19 (32%)     19 (33%)     12 (20%)     21 (35%)                               
      Pars Intermedia, Hyperplasia, Tubular                                                   1 (2%)                                
   Thyroid Gland                                      (60)         (60)         (60)         (60)                                   
      C-Cell, Hyperplasia                              3 (5%)       3 (5%)       6 (10%)      4 (7%)                                
      C-Cell, Infiltration Cellular                                 1 (2%)                                                          
      Follicle, Dilatation                             2 (3%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (60)         (60)         (58)         (60)                                   
      Ectasia                                                       1 (2%)                    2 (3%)                                
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                      1 (2%)       2 (3%)                                                          
      Inflammation, Chronic                                                                   1 (2%)                                
      Inflammation, Suppurative                        6 (10%)      2 (3%)       4 (7%)       3 (5%)                                
   Prostate                                           (60)         (60)         (60)         (60)                                   
      Inflammation                                                               1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Suppurative                                     1 (2%)                    1 (2%)                                
   Seminal Vesicle                                    (60)         (60)         (60)         (60)                                   
      Fibrosis                                                                   1 (2%)                                             
   Testes                                             (60)         (60)         (60)         (60)                                   
      Atrophy                                          1 (2%)                                                                       
      Germinal Epithelium, Atrophy                     2 (3%)       4 (7%)       6 (10%)      3 (5%)                                
      Interstitial Cell, Hyperplasia                   1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)         (60)         (60)                                   
      Fibrosis                                                                                1 (2%)                                
      Hyperplasia                                      1 (2%)                                                                       
   Lymph Node                                         (5)          (8)          (5)          (9)                                    
      Lumbar, Angiectasis                                                                     1 (11%)                               
      Mediastinal, Angiectasis                                      1 (13%)                                                         
      Mediastinal, Pigmentation, Hemosiderin                                     1 (20%)                                            
      Renal, Pigmentation, Hemosiderin                                                        1 (11%)                               
   Lymph Node, Mandibular                             (60)         (59)         (60)         (58)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Infiltration Cellular, Plasma Cell                                                      1 (2%)                                
   Lymph Node, Mesenteric                             (59)         (60)         (60)         (60)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Congestion                                                                              1 (2%)                                
      Fibrosis                                                                                1 (2%)                                
      Inflammation, Suppurative                                                  1 (2%)                                             
   Spleen                                             (60)         (60)         (60)         (60)                                   
      Fibrosis                                        11 (18%)     11 (18%)      6 (10%)      8 (13%)                               
      Hematopoietic Cell Proliferation                 3 (5%)       3 (5%)       4 (7%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Necrosis                                                      1 (2%)                                                          
   Thymus                                             (55)         (55)         (58)         (57)                                   
      Atrophy                                          2 (4%)                                 1 (2%)                                
      Congestion                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (55)         (57)         (57)         (56)                                   
      Hyperplasia, Cystic                              2 (4%)       1 (2%)       1 (2%)                                             
      Lymphatic, Ectasia                               1 (2%)                                                                       
   Skin                                               (60)         (60)         (60)         (59)                                   
      Hyperkeratosis                                   2 (3%)                                                                       
      Hyperplasia, Basal Cell                                                    1 (2%)                                             
      Inflammation, Acute                              1 (2%)                                                                       
      Ulcer                                                         1 (2%)                                                          
      Dermis, Fibrosis, Focal                                       1 (2%)                                                          
      Hair Follicle, Atrophy, Focal                                 1 (2%)                                                          
      Subcutaneous Tissue, Edema                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)         (60)         (60)                                   
      Fibrous Osteodystrophy                                        1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)         (60)                                   
      Hypothalamus, Hemorrhage                         1 (2%)                                                                       
      Medulla, Gliosis                                                                        1 (2%)                                
      Ventricle, Hydrocephalus                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05121-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 04/03/96  
Route: GAVAGE                                                                                                     Time: 21:10:36  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     O MG/KG      1 MG/KG      5 MG/KG      25 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (60)                                   
      Ectopic Tissue                                                1 (2%)                                                          
      Foreign Body                                     1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Granulomatous                      3 (5%)                                 1 (2%)                                
      Inflammation, Subacute                           1 (2%)                    1 (2%)       3 (5%)                                
      Alveolar Epithelium, Hyperplasia                 1 (2%)       2 (3%)       1 (2%)       1 (2%)                                
      Alveolus, Edema                                                                         1 (2%)                                
      Interstitium, Inflammation                                                 1 (2%)                                             
      Pleura, Inflammation, Chronic                    1 (2%)                                                                       
   Nose                                               (60)         (60)         (60)         (60)                                   
      Foreign Body                                     1 (2%)                                                                       
      Inflammation, Suppurative                        2 (3%)       1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (6)                       (1)          (2)                                    
      Inflammation, Chronic                            3 (50%)                                                                      
      External Ear, Hyperkeratosis                     2 (33%)                                                                      
      External Ear, Inflammation, Chronic                                                     1 (50%)                               
   Eye                                                (1)          (1)          (1)          (1)                                    
      Degeneration                                     1 (100%)                                                                     
      Lens, Cataract                                                             1 (100%)     1 (100%)                              
   Harderian Gland                                    (1)                       (1)                                                 
      Inflammation, Suppurative                                                  1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (60)                                   
      Cyst                                                          1 (2%)                                                          
      Nephropathy                                     57 (95%)     54 (90%)     57 (95%)     50 (83%)                               
      Renal Tubule, Pigmentation, Hemosiderin                                    1 (2%)                                             
      Transitional Epithelium, Hyperplasia                                                    1 (2%)                                
   Urinary Bladder                                    (60)         (60)         (60)         (60)                                   
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Suppurative                                     1 (2%)                                                          
      Ulcer                                            1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------